Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - CAPITAL EXPENDITURES
Capital Expenditures REGN - Regeneron Pharmaceuticals, Inc.
-756 M
LAST VALUE
-13.18%
2 YEAR CAGR
-11.96%
5 YEAR CAGR
-8.54%
10 YEAR CAGR